Autoimmune nodopathies: treatable neuropathies beyond traditional classifications

Precise characterisation of the target antigens and autoantibody isotypes improves patient care in inflammatory neuropathies

Antibodies targeting all neurofascin isoforms (pan-neurofascin) have been associated with variants of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) that include ataxic presentations, cranial nerve involvement, respiratory failure and association with other autoimmune disorders .1 2 Fehmi et al describe a severe, yet treatable, neuropathy associated with anti-pan-neurofascin antibodies of the IgG1 isotype.3

Nodo-paranodal antibodies have been described in neuropathies fulfilling CIDP diagnostic criteria. However, a significant proportion of patients harbouring any nodo-paranodal autoantibody (contactin-1, contactin-associated protein-1, neurofascin-155 or pan-neurofascin) presents as rapidly progressive, aggressive (including the need of intensive care unit admission and need of mechanical ventilation) neuropathies, often leading to an initial diagnosis of Guillain-Barré syndrome. Fehmi et al describe that anti-pan-neurofascin IgG1 antibodies associate with an aggressive (often fatal) neuropathy, leading to profound tetraplegia, intensive care unit admission and,…

Read article at journal's website

Related Articles

Responses

Your email address will not be published. Required fields are marked *